Skip to main content

Published locations for FDA accepts priority review of dupilumab for adolescent atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA accepts priority review of dupilumab for adolescent atopic dermatitis

User login

  • Reset your password
  • /content/fda-accepts-priority-review-dupilumab-adolescent-atopic-dermatitis
  • /edermatologynews/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent
  • /familypracticenews/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent
  • /pediatricnews/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent
  • /pediatrics/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent-atopic
  • /dermatology/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent-atopic
  • /familymedicine/article/184011/atopic-dermatitis/fda-accepts-priority-review-dupilumab-adolescent